Is the mid-term cure rate of lymphoma high?

Many people are afraid of cancer and think that all tumors are incurable, which leads to a loss of confidence in treatment and the missed treatment opportunities. In the past 10 to 20 years, due to the progress of science and technology, the treatment of malignant tumors has made rapid progress and the treatment effect has been significantly improved. Lymphoma is one of the malignant tumors with better treatment effect. Although some malignant lymphomas are relatively hidden and difficult to detect, if they can be detected early and treated in time, the cure rate will be greatly improved.

Is the cure rate of lymphoma high in the mid-term? The efficacy of different types and stages of lymphoma varies greatly. Generally speaking, the efficacy of Hodgkin's lymphoma is significantly better than that of non-Hodgkin's lymphoma. For Hodgkin's lymphoma in stages I and II, the 5-year survival rate can reach more than 95%, of which more than 75% of patients can survive for more than 15 years. The vast majority of patients will be cured, and the mortality rate is equal to that of most normal people. In classic textbooks, Hodgkin's lymphoma has been listed as one of the curable malignant tumors, but the necessary premise is still early detection and reasonable treatment. The 5-year survival rate of Hodgkin's lymphoma in stages III and IV is about 70%, and most patients will be cured.

Low-risk non-Hodgkin's lymphoma, stage I and stage II: the average 10-year survival rate is about 65%, and a few patients may be cured; stage III and stage IV: the average 10-year survival rate is about 45%, and there is currently no cure. Moderate-risk stage I and stage II: the average 10-year survival rate is about 65%, and many patients may be cured; stage III and stage IV: the average 5-year survival rate is about 60%, and many patients may be cured. High-risk: Burkitt lymphoma: the average 5-year survival rate is about 50%, and some patients may be cured; precursor lymphoblastic lymphoma: the average 3-year survival rate is about 70%, and a few patients may be cured; adult T-cell lymphoma: the average 4-year survival rate is about 20%, and the possibility of cure is very small.

With the continuous improvement of diagnosis and treatment techniques, the treatment effect of lymphoma will become better and better, so our patients and their families must build up confidence in defeating the disease.